Page last updated: 2024-10-23

bendazac and Hemolysis

bendazac has been researched along with Hemolysis in 1 studies

bendazac : A monocarboxylic acid that is glycolic acid in which the hydrogen attached to the 2-hydroxy group is replaced by a 1-benzyl-1H-indazol-3-yl group. Although it has anti-inflammatory, antinecrotic, choleretic and antilipidaemic properties and has been used for the treatment of various inflammatory skin disorders, its principal effect is to inhibit the denaturation of proteins. Its lysine salt is used in the management of cataracts.

Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.

Research Excerpts

ExcerptRelevanceReference
"Bendazac is a drug previously reported to prevent protein denaturation produced by various agents, including free radicals."1.28Photosensitized haemolysis of human erythrocytes is reduced by bendazac. ( Ciancarelli-Tozzi, MG; Finazzi-Agro, A; Silvestrini, B, 1989)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ciancarelli-Tozzi, MG1
Silvestrini, B1
Finazzi-Agro, A1

Other Studies

1 other study available for bendazac and Hemolysis

ArticleYear
Photosensitized haemolysis of human erythrocytes is reduced by bendazac.
    Drugs under experimental and clinical research, 1989, Volume: 15, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Hemolysis; Humans; In Vitro Techniques; Indazoles; Photolys

1989